ADHD Medications

You Asked: In a Woman with ADHD, Should You Continue Treatment with a Stimulant During the Postpartum Period?

A growing body of literature supports the reproductive safety of stimulants in pregnant women and suggests that not treating may have negative consequences for the mother and her child.

By |2024-06-26T12:48:46-04:00May 21st, 2024|ADHD, ADHD Medications, Medication, Postpartum Psychiatric Disorders, Treatment, You Asked|Comments Off on You Asked: In a Woman with ADHD, Should You Continue Treatment with a Stimulant During the Postpartum Period?

Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations

Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]

By |2024-05-16T07:00:11-04:00October 11th, 2023|ADHD Medications, Essential Reads, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations

Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

By |2023-10-03T12:00:00-04:00October 11th, 2023|ADHD Medications, Neurodevelopmental Disorders, Outcomes, Pregnancy & Medications|Comments Off on Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications

Essential Reads: More Data on ADHD Medications and Pregnancy

Women with attention-deficit/hyperactivity disorder (ADHD) often discontinue psychostimulant  medications during pregnancy, especially if they have milder symptoms.  While this approach makes sense in terms of limiting unnecessary exposures in women with what appears to [...]

By |2021-01-19T10:49:57-04:00January 20th, 2021|ADHD Medications, Essential Reads, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Essential Reads: More Data on ADHD Medications and Pregnancy

Modafinil and Armodafinil During Pregnancy: Data to Suggest Increased Risk of Malformations

As soon as we published this article on the use of modafinil during pregnancy, another study was published which included data on the reproductive safety of modafinil and armodafinil from the US Provigil/Nuvigil Pregnancy [...]

By |2022-01-20T18:11:36-04:00November 4th, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Modafinil and Armodafinil During Pregnancy: Data to Suggest Increased Risk of Malformations

New (But Still Not Enough) Data on Modafinil and Pregnancy

Modafinil (brand name Provigil) is a wake-promoting agent which is used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.  It is also used in other settings, often in [...]

By |2020-11-17T16:01:54-04:00October 20th, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on New (But Still Not Enough) Data on Modafinil and Pregnancy

Preliminary Data Raises Concerns About Modafinil Use in Pregnancy

Modafinil (brand name Provigil) is a wake-promoting agent which is used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.  It is also used to in others settings, often [...]

By |2020-11-01T21:53:56-04:00January 31st, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Preliminary Data Raises Concerns About Modafinil Use in Pregnancy
Go to Top